- Home
- FRME vs OMCL Comparison
FRME vs OMCL Comparison
Compare FRME & OMCL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FRME
- OMCL
- Stock Information
- Founded
- FRME 1893
- OMCL 1992
- Country
- FRME United States
- OMCL United States
- Employees
- FRME N/A
- OMCL N/A
- Industry
- FRME Major Banks
- OMCL Computer Manufacturing
- Sector
- FRME Finance
- OMCL Technology
- Exchange
- FRME Nasdaq
- OMCL Nasdaq
- Market Cap
- FRME 2.6B
- OMCL 2.0B
- IPO Year
- FRME N/A
- OMCL 2001
- Fundamental
- Price
- FRME $44.35
- OMCL $43.85
- Analyst Decision
- FRME Buy
- OMCL Buy
- Analyst Count
- FRME 5
- OMCL 6
- Target Price
- FRME $47.50
- OMCL $52.33
- AVG Volume (30 Days)
- FRME 239.5K
- OMCL 319.5K
- Earning Date
- FRME 01-30-2025
- OMCL 02-06-2025
- Dividend Yield
- FRME 3.16%
- OMCL N/A
- EPS Growth
- FRME N/A
- OMCL N/A
- EPS
- FRME 3.41
- OMCL N/A
- Revenue
- FRME $610,994,000.00
- OMCL $1,064,205,999.00
- Revenue This Year
- FRME N/A
- OMCL N/A
- Revenue Next Year
- FRME $2.46
- OMCL $5.24
- P/E Ratio
- FRME $13.01
- OMCL N/A
- Revenue Growth
- FRME N/A
- OMCL N/A
- 52 Week Low
- FRME $30.55
- OMCL $25.12
- 52 Week High
- FRME $46.13
- OMCL $55.75
- Technical
- Relative Strength Index (RSI)
- FRME 70.30
- OMCL 48.89
- Support Level
- FRME $43.08
- OMCL $42.19
- Resistance Level
- FRME $45.20
- OMCL $45.87
- Average True Range (ATR)
- FRME 1.10
- OMCL 1.03
- MACD
- FRME 0.58
- OMCL 0.18
- Stochastic Oscillator
- FRME 86.09
- OMCL 49.50
About FRME First Merchants Corporation
First Merchants Corp, through its subsidiaries, provides its customers with financial services delivered locally by bankers. It offers personal banking, business banking, real estate mortgage lending, cash management services, brokerage, wealth management, and insurance. The company reports in only one segment which is community banking.
About OMCL Omnicell Inc. ($0.001 par value)
Omnicell Inc provides automation and business analytics software for healthcare providers. It helps its customers to define and deliver cost-effective medication management that is designed to equip and empower pharmacists and nurses to focus on patient care rather than administrative tasks, and to drive improved clinical, operational, and financial outcomes across all care settings. Omnicell generates the vast majority of its revenue in the United States.